RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
批准号:
8888575
负责人:
STEPHEN F VATNER
金额:
$62.94万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-10 至 2019-01-31
关键词:
AcuteAdenylate CyclaseAdhesionsAdverse effectsAmericasAngiogenic FactorApoptosisAreaAtomic Force MicroscopyBlood CirculationBlood VesselsBlood flowCardiacCardiovascular DiseasesCause of DeathCell Culture TechniquesCell SurvivalCellsCessation of lifeChronicCicatrixCoronary CirculationCyclic AMPCyclic AMP-Dependent Protein KinasesDataDevelopmentDistalFibrosisGTP-Binding Protein RegulatorsGenesGrantGrowth FactorGuanosine TriphosphateHealthHeartHeart DiseasesHeart failureHypertrophyIndividualIschemiaKnock-outKnockout MiceLimb structureLongevityMEKsMediatingModelingMusMuscle CellsMyocardial IschemiaNitric OxideOxidative StressPathway interactionsReperfusion TherapyRiskRoleSignal PathwaySignal TransductionTimeTissuesVascular Endothelial Growth FactorsVentricular Remodelingangiogenesiscoronary artery occlusionimprovedin vivonovelprotective effectpublic health relevancereceptor
中文摘要
描述(由申请人提供):从未研究过G蛋白信号传导调节因子14(RGS 14)在心脏中的作用,我们发现RGS 14 KO小鼠通过血管生成/动脉生成而免受急性和慢性缺血的不良影响,从而保护心肌重塑和心力衰竭的发展。为了实现这一提议的目的,我们将研究以下假设:我们的第一个假设是,破坏RGS 14是一种新的机制,以保护心脏免受慢性心肌缺血,通过血管生成和动脉生成。我们的第二个假设是,急性和慢性缺血保护的机制涉及Gi AC/cAMP和Ras介导的MEK/ERK途径的激活,并因此一氧化氮(NO)/VEGF激活,以及阻断氧化应激。 RGS 14敲除(KO)小鼠的一个特别新颖的特征是其保护免受急性和慢性心肌缺血以及诱导动脉生成/血管生成的能力。第二个新的特征,强调了研究具有多种效应的基因(如RGS 14)抑制的重要性,它引起了由几个远端信号通路介导的这些不寻常的保护作用,这些远端信号通路的组合可能比任何一个单独的机制更有益。
英文摘要
DESCRIPTION (provided by applicant): The role of the regulator of G protein signaling 14 (RGS14) in the heart has never been studied, and we found that the RGS14 KO mice are protected from the adverse effects of acute and chronic ischemia, through angiogenesis/arteriogenesis, which protects from myocardial remodeling and development of heart failure. To accomplish the aims of this proposal, we will examine the following hypotheses: Our first hypothesis is that disruption of RGS14 is a novel mechanism to protect the heart against chronic myocardial ischemia through angiogenesis and arteriogenesis. Our second hypothesis is that the mechanism of acute and chronic ischemic protection involves Gi AC/cAMP and Ras-mediated activation of the MEK/ERK pathway and consequently nitric oxide (NO)/VEGF activation, as well as blocking oxidative stress. A particularly novel feature of the RGS14 Knockout (KO) mouse is its ability to protect against both acute and chronic myocardial ischemia and to induce arteriogenesis/angiogenesis. A second novel feature, that underlies the importance of studying inhibition of a gene with multiple effects, such as RGS14, is that it elicit these unusual protective effects mediated by several distal signaling pathways, which in their combination are likely more salutary than any one of the individual mechanisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Pharmacological Inhibitor of Adenylyl Cyclase Type 5 to Treat Alzheimer's Disease
-
批准号:10608477
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2022
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle and Brown Adipose Mechanisms Mediating Cardiovascular Risk Factor Protection in RGS14 KO
-
批准号:9900047
-
项目类别:
-
资助金额:$53.43万
-
财政年份:2017
-
负责人:STEPHEN F VATNER
-
依托单位:
Angiogenesis Protection Induced by sFRP3 Myocyte/Vascular Cross-Talk
-
批准号:9900045
-
项目类别:
-
资助金额:$56.45万
-
财政年份:2017
-
负责人:STEPHEN F VATNER
-
依托单位:
Vascular Protection in Hibernating Woodchucks
-
批准号:9020511
-
项目类别:
-
资助金额:$45.47万
-
财政年份:2016
-
负责人:STEPHEN F VATNER
-
依托单位:
RGS 14 Disruption, Vascular Effects Leading to Cardioprotection
-
批准号:9102537
-
项目类别:
-
资助金额:$5.19万
-
财政年份:2015
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8764029
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2013
-
负责人:STEPHEN F VATNER
-
依托单位:
Longevity and Stress Resistance
-
批准号:8682004
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2013
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
-
批准号:9513046
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8193326
-
项目类别:
-
资助金额:$46.88万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8497469
-
项目类别:
-
资助金额:$43.02万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8323343
-
项目类别:
-
资助金额:$45.33万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in RGS14 KO
-
批准号:9113803
-
项目类别:
-
资助金额:$50.08万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Skeletal Muscle Basis for Improved Exercise Endurance in AC5 KO
-
批准号:8725726
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2011
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:7866136
-
项目类别:
-
资助金额:$49.13万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8828759
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
AC5 Inhibitor Treatment for Heart Failure
-
批准号:8010655
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8724853
-
项目类别:
-
资助金额:$44.22万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Intrinsic Vascular Smooth Muscle Cell Stiffness
-
批准号:8586272
-
项目类别:
-
资助金额:$48.74万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
AC5 Inhibitor Treatment for Heart Failure
-
批准号:7867014
-
项目类别:
-
资助金额:$77.91万
-
财政年份:2010
-
负责人:STEPHEN F VATNER
-
依托单位:
Adenylyl cyclase isoforms in hypertrophy and heart failure
-
批准号:7741542
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2009
-
负责人:STEPHEN F VATNER
-
依托单位:
海外基金